Tudor Investment Corp
DAWN

Tudor Investment Corp’s Day One Biopharmaceuticals DAWN Stock Holding History

Tudor Investment Corp’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62,316
Closed -$581K – 3740
2025
Q4 		$581K Buy
62,316
+12,766
+26% +$107K ﹤0.01% 2630
2025
Q3 		$349K Buy
49,550
+13,157
+36% +$90.5K ﹤0.01% 2885
2025
Q2 		$237K Sell
36,393
-14,401
-28% -$99.1K ﹤0.01% 3014
2025
Q1 		$403K Buy
+50,794
New +$547K ﹤0.01% 2409
2024
Q4 		– Sell
-55,122
Closed -$768K – 3110
2024
Q3 		$768K Buy
55,122
+3,231
+6% +$46.1K ﹤0.01% 1781
2024
Q2 		$715K Buy
51,891
+8,301
+19% +$121K ﹤0.01% 1639
2024
Q1 		$720K Buy
43,590
+10,223
+31% +$153K ﹤0.01% 1486
2023
Q4 		$487K Buy
+33,367
New +$405K ﹤0.01% 1809
2023
Q3 		– Sell
-28,163
Closed -$336K – 2387
2023
Q2 		$336K Buy
28,163
+17,035
+153% +$222K ﹤0.01% 1935
2023
Q1 		$149K Buy
+11,128
New +$217K ﹤0.01% 2218
2022
Q4 		– Sell
-36,544
Closed -$732K – 2481
2022
Q3 		$732K Buy
+36,544
New +$777K 0.02% 1140

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Tudor Investment Corp's DAWN Position: Q1 2026 in Review

Tudor Investment Corp sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 62,316 shares — an estimated $581K sold.

Tudor Investment Corp first reported a position in DAWN in Q3 2022 and held it in 11 quarters. The position peaked at $768K in Q3 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Tudor Investment Corp reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 62,316 Day One Biopharmaceuticals shares in Q1 2026, an estimated $581K.
  • Tudor Investment Corp first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 11 quarters.
  • Tudor Investment Corp's Day One Biopharmaceuticals position peaked at $768K in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.